Thymic squamous cell carcinoma producing parathyroid hormone-related protein and CYFRA 21-1

Internal Medicine

Volumn 43, Issue 6, 2004, Pages 493-495

  Yoshiike, Fumiaki ^b   Koizumi, Tomonobu ^b   Yoneyama, Ayako ^b   Komatu, Michiharu ^b   Yamaguchi, Shinji ^b   Hanaoka, Masayuki ^b   Kubo, Keishi ^b   Eda, Seiichirou ^a  

^a National Hospital Organization   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium; CYFRA 21 1; Mediastinal tumor; Paraneoplastic syndrome; PTHrP

Indexed keywords

CALCIUM; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKERATIN 19 FRAGMENT; DOXORUBICIN; MONOCLONAL ANTIBODY; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN; STEROID; VINCRISTINE;

ADULT; ARTICLE; AUTOPSY; CALCIUM BLOOD LEVEL; CANCER CELL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; MALE; MEDIASTINUM MASS; NEEDLE BIOPSY; PARANEOPLASTIC SYNDROME; PERCUTANEOUS BIOPSY; PERICARDIAL EFFUSION; PROTEIN BLOOD LEVEL; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; THYMUS CANCER; TUMOR DIFFERENTIATION;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARCINOMA, SQUAMOUS CELL; CISPLATIN; CYCLOPHOSPHAMIDE; DIPHOSPHONATES; DOXORUBICIN; FATAL OUTCOME; HUMANS; KERATINS; MALE; MEDIASTINUM; MIDDLE AGED; PARATHYROID HORMONE-RELATED PROTEIN; THYMUS NEOPLASMS; VINCRISTINE;

EID: 3242793408     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.493     Document Type: Article

References (10)

1. Burtis WJ, Brady TG, Orloff JJ, et al. Immunochemical characterization of circulating parathyroid hormone - related protein in patients with humonal hypercalcemia of cancer. N Engl J Med 322: 1106-1112, 1990.
2. Pecherstorfer M, Schilling T, Blind E, et al. Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. J Clin Endocrinol Metab 78: 1268-1270, 1994.
3. Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 67: 1025-1032, 1991.
4. Truong LD, Mody DR, Cagle PT, Jackson-York GL, Schwartz MR, Wheeler TM. Thymic carcinoma. A clinicopathologic study of 13 cases. Am J Surg Pathol 14: 151-166, 1990.
5. Koizumi T, Takabayashi Y, Yamagishi S, et al. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine and cyclophosphamide (ADOC chemotherapy). Am J Clin Oncol 25: 266-268, 2002.
6. Negron-Soto JM, Cascade PN. Squamous cell carcinoma of the thymus with paraneoplastic hypercalcemia. Clin Imaging 19: 122-124, 1995.
7. Suzuki K, Tanaka H, Shibusa T, et al. Parathyroid-hormone-related-protein-producing thymic carcinoma presenting as a giant extrathoracic mass. Respiration 65: 83-85, 1998.
8. Rapellino M, Niklinski J, Pecchio F, et al. CYFRA 21-1 as a tumor marker for bronchogenic carcinoma. Eur Respir J 8: 407-410, 1995.
9. Pujol JL, Grenier J, Daures JP, Daver A, Pujol H, Michel FB. Serum fragment of cytokeratin submit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 53: 61-66, 1993.
10. Fujikawa M, Takata Y, Okamura K, et al. Hypercalcemia associated with parathyroid hormone - related protein at the terminal stage of uncomplicated squamous cell carcinoma in the head and neck region. Head Neck 24: 56-62, 2002.